United States Tuberculosis Drug Market Report 2017

August 2017 | 95 pages | ID: UEE3B05B609EN
QYResearch

Abstracts

In this report, the United States Tuberculosis Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Tuberculosis Drug in these regions, from 2012 to 2022 (forecast).

United States Tuberculosis Drug market competition by top manufacturers/players, with Tuberculosis Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Lupin
• Otsuka Novel Products
• Pfizer
• Sandoz
• Sanofi
• AstraZeneca
• Archivel Farma
• EIKEN CHEMICAL
• Cepheid
• Epistem

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Active TB
• Latent TB

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Tuberculosis Drug for each application, including

• First-line anti-TB drugs
• Second-line anti-TB drugs

Contents

United States Tuberculosis Drug Market Report 2017

1 TUBERCULOSIS DRUG OVERVIEW

1.1 Product Overview and Scope of Tuberculosis Drug
1.2 Classification of Tuberculosis Drug by Product Category
  1.2.1 United States Tuberculosis Drug Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Tuberculosis Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Active TB
  1.2.4 Latent TB
1.3 United States Tuberculosis Drug Market by Application/End Users
  1.3.1 United States Tuberculosis Drug Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 First-line anti-TB drugs
  1.3.3 Second-line anti-TB drugs
1.4 United States Tuberculosis Drug Market by Region
  1.4.1 United States Tuberculosis Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Tuberculosis Drug Status and Prospect (2012-2022)
  1.4.3 Southwest Tuberculosis Drug Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Tuberculosis Drug Status and Prospect (2012-2022)
  1.4.5 New England Tuberculosis Drug Status and Prospect (2012-2022)
  1.4.6 The South Tuberculosis Drug Status and Prospect (2012-2022)
  1.4.7 The Midwest Tuberculosis Drug Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Tuberculosis Drug (2012-2022)
  1.5.1 United States Tuberculosis Drug Sales and Growth Rate (2012-2022)
  1.5.2 United States Tuberculosis Drug Revenue and Growth Rate (2012-2022)

2 UNITED STATES TUBERCULOSIS DRUG MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Tuberculosis Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Tuberculosis Drug Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Tuberculosis Drug Average Price by Players/Suppliers (2012-2017)
2.4 United States Tuberculosis Drug Market Competitive Situation and Trends
  2.4.1 United States Tuberculosis Drug Market Concentration Rate
  2.4.2 United States Tuberculosis Drug Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Tuberculosis Drug Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES TUBERCULOSIS DRUG SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Tuberculosis Drug Sales and Market Share by Region (2012-2017)
3.2 United States Tuberculosis Drug Revenue and Market Share by Region (2012-2017)
3.3 United States Tuberculosis Drug Price by Region (2012-2017)

4 UNITED STATES TUBERCULOSIS DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Tuberculosis Drug Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Tuberculosis Drug Revenue and Market Share by Type (2012-2017)
4.3 United States Tuberculosis Drug Price by Type (2012-2017)
4.4 United States Tuberculosis Drug Sales Growth Rate by Type (2012-2017)

5 UNITED STATES TUBERCULOSIS DRUG SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Tuberculosis Drug Sales and Market Share by Application (2012-2017)
5.2 United States Tuberculosis Drug Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES TUBERCULOSIS DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Lupin
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Tuberculosis Drug Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Lupin Tuberculosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Otsuka Novel Products
  6.2.2 Tuberculosis Drug Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Otsuka Novel Products Tuberculosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Pfizer
  6.3.2 Tuberculosis Drug Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Pfizer Tuberculosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Sandoz
  6.4.2 Tuberculosis Drug Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Sandoz Tuberculosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Sanofi
  6.5.2 Tuberculosis Drug Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Sanofi Tuberculosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 AstraZeneca
  6.6.2 Tuberculosis Drug Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 AstraZeneca Tuberculosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Archivel Farma
  6.7.2 Tuberculosis Drug Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Archivel Farma Tuberculosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 EIKEN CHEMICAL
  6.8.2 Tuberculosis Drug Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 EIKEN CHEMICAL Tuberculosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Cepheid
  6.9.2 Tuberculosis Drug Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Cepheid Tuberculosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Epistem
  6.10.2 Tuberculosis Drug Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Epistem Tuberculosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 TUBERCULOSIS DRUG MANUFACTURING COST ANALYSIS

7.1 Tuberculosis Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Tuberculosis Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Tuberculosis Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Tuberculosis Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES TUBERCULOSIS DRUG MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Tuberculosis Drug Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Tuberculosis Drug Sales Volume Forecast by Type (2017-2022)
11.3 United States Tuberculosis Drug Sales Volume Forecast by Application (2017-2022)
11.4 United States Tuberculosis Drug Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Tuberculosis Drug
Figure United States Tuberculosis Drug Market Size (MT) by Type (2012-2022)
Figure United States Tuberculosis Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Active TB Product Picture
Figure Latent TB Product Picture
Figure United States Tuberculosis Drug Market Size (MT) by Application (2012-2022)
Figure United States Sales Market Share of Tuberculosis Drug by Application in 2016
Figure First-line anti-TB drugs Examples
Figure Second-line anti-TB drugs Examples
Figure United States Tuberculosis Drug Market Size (Million USD) by Region (2012-2022)
Figure The West Tuberculosis Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Tuberculosis Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Tuberculosis Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Tuberculosis Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Tuberculosis Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Tuberculosis Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Tuberculosis Drug Sales (MT) and Growth Rate (2012-2022)
Figure United States Tuberculosis Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Tuberculosis Drug Market Major Players Product Sales Volume (MT) (2012-2017)
Table United States Tuberculosis Drug Sales (MT) of Key Players/Suppliers (2012-2017)
Table United States Tuberculosis Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Tuberculosis Drug Sales Share by Players/Suppliers
Figure 2017 United States Tuberculosis Drug Sales Share by Players/Suppliers
Figure United States Tuberculosis Drug Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Tuberculosis Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Tuberculosis Drug Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Tuberculosis Drug Revenue Share by Players/Suppliers
Figure 2017 United States Tuberculosis Drug Revenue Share by Players/Suppliers
Table United States Market Tuberculosis Drug Average Price (USD/Kg) of Key Players/Suppliers (2012-2017)
Figure United States Market Tuberculosis Drug Average Price (USD/Kg) of Key Players/Suppliers in 2016
Figure United States Tuberculosis Drug Market Share of Top 3 Players/Suppliers
Figure United States Tuberculosis Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Tuberculosis Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Tuberculosis Drug Product Category
Table United States Tuberculosis Drug Sales (MT) by Region (2012-2017)
Table United States Tuberculosis Drug Sales Share by Region (2012-2017)
Figure United States Tuberculosis Drug Sales Share by Region (2012-2017)
Figure United States Tuberculosis Drug Sales Market Share by Region in 2016
Table United States Tuberculosis Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Tuberculosis Drug Revenue Share by Region (2012-2017)
Figure United States Tuberculosis Drug Revenue Market Share by Region (2012-2017)
Figure United States Tuberculosis Drug Revenue Market Share by Region in 2016
Table United States Tuberculosis Drug Price (USD/Kg) by Region (2012-2017)
Table United States Tuberculosis Drug Sales (MT) by Type (2012-2017)
Table United States Tuberculosis Drug Sales Share by Type (2012-2017)
Figure United States Tuberculosis Drug Sales Share by Type (2012-2017)
Figure United States Tuberculosis Drug Sales Market Share by Type in 2016
Table United States Tuberculosis Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Tuberculosis Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Tuberculosis Drug by Type (2012-2017)
Figure Revenue Market Share of Tuberculosis Drug by Type in 2016
Table United States Tuberculosis Drug Price (USD/Kg) by Types (2012-2017)
Figure United States Tuberculosis Drug Sales Growth Rate by Type (2012-2017)
Table United States Tuberculosis Drug Sales (MT) by Application (2012-2017)
Table United States Tuberculosis Drug Sales Market Share by Application (2012-2017)
Figure United States Tuberculosis Drug Sales Market Share by Application (2012-2017)
Figure United States Tuberculosis Drug Sales Market Share by Application in 2016
Table United States Tuberculosis Drug Sales Growth Rate by Application (2012-2017)
Figure United States Tuberculosis Drug Sales Growth Rate by Application (2012-2017)
Table Lupin Basic Information List
Table Lupin Tuberculosis Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Lupin Tuberculosis Drug Sales Growth Rate (2012-2017)
Figure Lupin Tuberculosis Drug Sales Market Share in United States (2012-2017)
Figure Lupin Tuberculosis Drug Revenue Market Share in United States (2012-2017)
Table Otsuka Novel Products Basic Information List
Table Otsuka Novel Products Tuberculosis Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Otsuka Novel Products Tuberculosis Drug Sales Growth Rate (2012-2017)
Figure Otsuka Novel Products Tuberculosis Drug Sales Market Share in United States (2012-2017)
Figure Otsuka Novel Products Tuberculosis Drug Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Tuberculosis Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Pfizer Tuberculosis Drug Sales Growth Rate (2012-2017)
Figure Pfizer Tuberculosis Drug Sales Market Share in United States (2012-2017)
Figure Pfizer Tuberculosis Drug Revenue Market Share in United States (2012-2017)
Table Sandoz Basic Information List
Table Sandoz Tuberculosis Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Sandoz Tuberculosis Drug Sales Growth Rate (2012-2017)
Figure Sandoz Tuberculosis Drug Sales Market Share in United States (2012-2017)
Figure Sandoz Tuberculosis Drug Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Tuberculosis Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Sanofi Tuberculosis Drug Sales Growth Rate (2012-2017)
Figure Sanofi Tuberculosis Drug Sales Market Share in United States (2012-2017)
Figure Sanofi Tuberculosis Drug Revenue Market Share in United States (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Tuberculosis Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure AstraZeneca Tuberculosis Drug Sales Growth Rate (2012-2017)
Figure AstraZeneca Tuberculosis Drug Sales Market Share in United States (2012-2017)
Figure AstraZeneca Tuberculosis Drug Revenue Market Share in United States (2012-2017)
Table Archivel Farma Basic Information List
Table Archivel Farma Tuberculosis Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Archivel Farma Tuberculosis Drug Sales Growth Rate (2012-2017)
Figure Archivel Farma Tuberculosis Drug Sales Market Share in United States (2012-2017)
Figure Archivel Farma Tuberculosis Drug Revenue Market Share in United States (2012-2017)
Table EIKEN CHEMICAL Basic Information List
Table EIKEN CHEMICAL Tuberculosis Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure EIKEN CHEMICAL Tuberculosis Drug Sales Growth Rate (2012-2017)
Figure EIKEN CHEMICAL Tuberculosis Drug Sales Market Share in United States (2012-2017)
Figure EIKEN CHEMICAL Tuberculosis Drug Revenue Market Share in United States (2012-2017)
Table Cepheid Basic Information List
Table Cepheid Tuberculosis Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Cepheid Tuberculosis Drug Sales Growth Rate (2012-2017)
Figure Cepheid Tuberculosis Drug Sales Market Share in United States (2012-2017)
Figure Cepheid Tuberculosis Drug Revenue Market Share in United States (2012-2017)
Table Epistem Basic Information List
Table Epistem Tuberculosis Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Epistem Tuberculosis Drug Sales Growth Rate (2012-2017)
Figure Epistem Tuberculosis Drug Sales Market Share in United States (2012-2017)
Figure Epistem Tuberculosis Drug Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Tuberculosis Drug
Figure Manufacturing Process Analysis of Tuberculosis Drug
Figure Tuberculosis Drug Industrial Chain Analysis
Table Raw Materials Sources of Tuberculosis Drug Major Players/Suppliers in 2016
Table Major Buyers of Tuberculosis Drug
Table Distributors/Traders List
Figure United States Tuberculosis Drug Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure United States Tuberculosis Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Tuberculosis Drug Price (USD/Kg) Trend Forecast (2017-2022)
Table United States Tuberculosis Drug Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Tuberculosis Drug Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Tuberculosis Drug Sales Volume (MT) Forecast by Type in 2022
Table United States Tuberculosis Drug Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Tuberculosis Drug Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Tuberculosis Drug Sales Volume (MT) Forecast by Application in 2022
Table United States Tuberculosis Drug Sales Volume (MT) Forecast by Region (2017-2022)
Table United States Tuberculosis Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Tuberculosis Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Tuberculosis Drug Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources